Navigation Links
Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
Date:11/12/2007

eline 0.61 vs. 1.47, respectively; p-value less than 0.01). Secondary endpoints included ACR 20, 50, and 70 over time, major clinical response (45 percent for ORENCIA plus MTX), DAS at one year (42.5 percent vs. 9.9 percent, respectively; p-value less than 0.001), joint space narrowing (mean change from baseline 0.46 vs. 0.97, respectively; p-value less than 0.01), total Sharp scores at one year (mean change from baseline 1.07 vs. 2.43, respectively; p-value less than 0.01), and SF-36 through one year (mean change from baseline 8.44 vs. 5.28, respectively; p-value less than 0.001). ATTAIN was a Phase III multi-center, randomized, double-blind, placebo-controlled trial with 391 patients treated at baseline who had active RA despite anti-TNF therapy (389 included in efficacy analyses). The study was double-blind through six months, followed by an ongoing, open-label, long- term extension study. A total of 217 (from the original 256) patients in the group treated with ORENCIA entered the long-term extensions study. Additional DMARDs, NSAIDs, and aspirin were added and/or adjusted at the discretion of the investigator in the long-term extension study. Primary reasons for discontinuation in the long-term extension studies were adverse events and lack of efficacy

Primary endpoints were ACR 20 at six months ORENCIA vs. placebo (50.4 placebo vs. 19.5 percent, respectively; p-value less than 0.001) and improvement in HAQ-DI at six months (47.3 percent vs. 23.3 percent, respectively; p-value less than 0.001). Secondary endpoints were ACR 20, 50, and 70 over time, DAS28 at six months (DAS28 less than or equal to 3.2, 18 percent and DAS28 less than 2.6; 11.1 percent) and SF-36 at six months (55.6 percent vs. 31.6 percent, respectively; p-value less than 0.001). In five clinical trials, the most serious adverse reactions were serious infections (3 percent ORENCIA(R) (abatacept) vs. 1.9 percent placebo) and malignancies (1.3 percent ORENCIA vs. 1.1 percent placebo). The mos
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
2. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
5. ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
11. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 Research and Markets  has announced ... report to their offering. ... to diagnose, monitor, and assess medical conditions, diseases, or ... outcomes for earlier and more targeted treatment. These tests ... accurate results. This kind of diagnostics provides early detection ...
(Date:7/22/2014)... 22, 2014  Based on its recent analysis ... & Sullivan recognizes Siemens Healthcare with the 2014 ... FREEZEit solution, which employs Siemens, MAGNETOM Aera and ... motion-insensitive imaging. The solution,s sophistication and utility in ... MRI imaging in the U.S. market. ...
(Date:7/22/2014)... , July 22, 2014  PuraMed BioScience®, ... of over-the-counter (OTC) medicinal and healthcare products, announced ... of Operation Troop Aid. "We are ... Russell Mitchell , CEO and Chairman of PuraMed ... women in combat zones experience migraines much more ...
Breaking Medicine Technology:Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3
... 24, 2012  Covance Inc. (NYSE: CVD ) today ... Health Care Conference on Tuesday, February  28, 2012 at 9:00 ... at www.covance.com . In order to register and download any ... Covance, with headquarters in Princeton, New Jersey, is one of ...
... products in the pipeline and more at the edge ... life of mature brands are critical to today,s pharmaceutical ... many as 10 years and billions of dollars to ... To help biopharmaceutical companies more effectively conduct ...
Cached Medicine Technology:Covance to Present at Citi 2012 Global Health Care Conference 2Report Delivers ROI Analysis on Key Lifecycle Management Strategies Utilized by the Pharmaceutical Industry 2
(Date:7/23/2014)... 23, 2014 Picnic Lunches, Residents of The ... outdoor concerts and festivals, while still dining on the fabulous ... concerts in the park or to the beach or museum ... great meal while they’re out,” said Brian Hughes, director of ... the residents are just loving.” , Hagopian, the executive chef ...
(Date:7/23/2014)... childbirth and post delivery may reduce the risk of ... perinatal psychiatrist, in a July 23 editorial in ... based on a new Chinese study that found women ... vaginal delivery had a much lower risk for postpartum ... "Maximizing pain control in labor and delivery with your ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Men and ... often spend a portion of their disposable income each ... is now promoting its best anti aging products guide ... , This products guide is now released and accessible ... Internet connection. Known retailers were selected and inserted into ...
(Date:7/22/2014)... Ticket Down is a reliable ... tickets at Sporting Park in Kansas City, MO. ... 23rd. Tickets can be conveniently printed out for this ... can be reached toll free at 1-877-870-3653. All tickets ... covered by Ticket Down's customer satisfaction guarantee. , About TicketDown.com: ...
(Date:7/22/2014)... (PRWEB) July 23, 2014 Recently, iFitDress.com, a ... women, has announced its new selection of white party ... announced that custom made outfits are now available on its ... order before the end of July can get a discounted ... company’s products are popular among international customers, so its marketing ...
Breaking Medicine News(10 mins):Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2Health News:Controlling childbirth pain tied to lower depression risk 2Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... As part of its efforts to improve the ... U.S. Pharmacopeial (USP) Convention this week reached three ... Because Chinese manufacturers supply so much of the ... three previous agreements between USP and other government ...
... Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) is an ... substrates to modify their functions. CaMKII alpha is ... brain, and is believed to be an essential mediator ... causative role of the enzymatic activity of CaMKII alpha ...
... speeds up the potty process, researchers say , FRIDAY, June ... trying to get toddlers to pee in the toilet. Now, ... century solution -- electronics. , Researchers at the University of ... especially day care attendants, when tots do their business in ...
... How to Reform Personalities Enduring Metaphysical "Black Hole" , ... question of whether intelligence is hereditary has always shared ... research studies that show cognitive differences across racial lines. ... Physical Violence" ( published by AuthorHouse ), ...
... Kensey Nash Corporation (Nasdaq: KNSY ), ... technologies for a wide range of medical procedures, announced ... rights plan. The rights plan is designed to protect ... practices or takeover bids and to prevent an acquiror ...
... to Advance Palliative Care Director, Diane E. Meier, MD, Points ... YORK, June 19 Nancy-Ann DeParle, Director of the White ... in a series of White House health care stakeholder discussions ... Care (CAPC) director, Diane E. Meier, MD, was asked to ...
Cached Medicine News:Health News:Drive for good quality medicines, foods reinforced by USP agreements with Chinese drug authorities 2Health News:Generation of a severe memory-deficit mutant mouse by exclusively eliminating the kinase activity of CaMKIIalpha 2Health News:Toilet Training Goes High Tech 2Health News:Toilet Training Goes High Tech 3Health News:Provocative New Nonfiction Addresses Spiritual Destiny 2Health News:Provocative New Nonfiction Addresses Spiritual Destiny 3Health News:Kensey Nash Corporation Adopts Stockholder Rights Plan 2Health News:Kensey Nash Corporation Adopts Stockholder Rights Plan 3Health News:Kensey Nash Corporation Adopts Stockholder Rights Plan 4Health News:White House Health Reform Stakeholder Discussion Brings Palliative Care to the Table 2
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes....
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
The Auto Suture™ ExtraHand™ balloon retractor is designed to be used during open surgery, gasless endoscopy, as well as endoscopy with gas insufflation....
Medicine Products: